The common view was that larger tumour size, the presence of vascular invasion, an abnormal contralateral thyroid lobe after hemithyroidectomy, aggressive histopathology and positive BRAF V600E were factors that would increase the intensity of follow‐up. This evidence concerns the gene BRAF and neoplasm.